Brett Wallden

1.4k total citations · 1 hit paper
17 papers, 938 citations indexed

About

Brett Wallden is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Brett Wallden has authored 17 papers receiving a total of 938 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cancer Research, 8 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Brett Wallden's work include Cancer Genomics and Diagnostics (5 papers), Breast Cancer Treatment Studies (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Brett Wallden is often cited by papers focused on Cancer Genomics and Diagnostics (5 papers), Breast Cancer Treatment Studies (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Brett Wallden collaborates with scholars based in United States, Canada and Denmark. Brett Wallden's co-authors include Torsten O. Nielsen, Naeem Dowidar, Sean Ferree, James J. Storhoff, Carl Schaper, Patrick Danaher, Amy Sullivan, Irena Pekker, Josue Samayoa and Rongze Lu and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Brett Wallden

17 papers receiving 920 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA)

2018 294 citations Patrick Danaher, Sarah Warren et al. Journal for ImmunoTherapy of Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brett Wallden United States	8	496	449	362	272	143	17	938
Mutsuko Yamamoto‐Ibusuki Japan	20	445 0.9×	509 1.1×	553 1.5×	250 0.9×	183 1.3×	45	1.1k
Marie‐Paule Sablin France	18	499 1.0×	354 0.8×	410 1.1×	289 1.1×	89 0.6×	50	942
Sharon B. Sams United States	17	514 1.0×	229 0.5×	382 1.1×	208 0.8×	134 0.9×	40	1.0k
Yoshiya Horimoto Japan	20	694 1.4×	378 0.8×	495 1.4×	235 0.9×	170 1.2×	97	1.2k
Atsushi Shimomura Japan	21	513 1.0×	595 1.3×	439 1.2×	213 0.8×	97 0.7×	48	1.1k
Laxmi Silwal‐Pandit Norway	13	420 0.8×	367 0.8×	404 1.1×	175 0.6×	70 0.5×	21	800
Aiko Sueta Japan	18	340 0.7×	487 1.1×	455 1.3×	185 0.7×	69 0.5×	45	947
Samira Majjaj Belgium	12	321 0.6×	449 1.0×	498 1.4×	145 0.5×	116 0.8×	24	902
Ali Amin‐Mansour United States	6	424 0.9×	243 0.5×	396 1.1×	319 1.2×	179 1.3×	9	983
Habib Hamidi United States	16	437 0.9×	310 0.7×	685 1.9×	335 1.2×	96 0.7×	41	1.2k

Countries citing papers authored by Brett Wallden

Since Specialization

Citations

This map shows the geographic impact of Brett Wallden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brett Wallden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brett Wallden more than expected).

Fields of papers citing papers by Brett Wallden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brett Wallden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brett Wallden. The network helps show where Brett Wallden may publish in the future.

Co-authorship network of co-authors of Brett Wallden

This figure shows the co-authorship network connecting the top 25 collaborators of Brett Wallden. A scholar is included among the top collaborators of Brett Wallden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brett Wallden. Brett Wallden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Warren, Sarah, Patrick Danaher, Afshin Mashadi-Hossein, et al.. (2019). Development of Gene Expression-Based Biomarkers on the nCounter® Platform for Immuno-Oncology Applications. Methods in molecular biology. 2055. 273–300. 3 indexed citations

Danaher, Patrick, Sarah Warren, Rongze Lu, et al.. (2018). Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA). Journal for ImmunoTherapy of Cancer. 6(1). 63–63. 294 indexed citations breakdown →

Church, S., Irena Pekker, Naeem Dowidar, et al.. (2018). Validating critical analytical variables of a multiplexed gene expression assay measuring tumor inflammation designed to predict response to anti-PD1 therapy.. Journal of Clinical Oncology. 36(5_suppl). 203–203. 2 indexed citations

Wallden, Brett, S. Church, Irena Pekker, et al.. (2018). Impact of tissue processing and interferents on the reproducibility and robustness of a multi-plex gene expression assay measuring tumor inflammation. Annals of Oncology. 29. viii425–viii425. 2 indexed citations

Wallden, Brett, Irena Pekker, Naeem Dowidar, et al.. (2017). Verification of the analytical performance of a molecular diagnostic for response to anti-PD1 therapy on the nCounter Dx Analysis System.. Journal of Clinical Oncology. 35(7_suppl). 8–8. 2 indexed citations

Chen, Ning, Patrick Danaher, Brett Wallden, et al.. (2016). Analytical Validation of the nCounter®-based Lymphoma Subtyping Test (LST) for Cell-of-Origin (COO) Identification in Formalin-Fixed Paraffin-Embedded (FFPE) Diffuse Large B-Cell Lymphoma (DLBCL) Specimens. Blood. 128(22). 2933–2933. 2 indexed citations

Wallden, Brett, Irena Pekker, Naeem Dowidar, et al.. (2016). Development and analytical performance of a molecular diagnostic for anti-PD1 response on the nCounter Dx Analysis System.. Journal of Clinical Oncology. 34(15_suppl). 3034–3034. 16 indexed citations

Wallden, Brett, James J. Storhoff, Torsten O. Nielsen, et al.. (2015). Development and verification of the PAM50-based Prosigna breast cancer gene signature assay. BMC Medical Genomics. 8(1). 54–54. 337 indexed citations

Storhoff, James J., Brett Wallden, Rita M. Braziel, et al.. (2015). Analytical Performance of Nanostring's Companion Diagnostic (CDx) Lymphoma Subtyping Test (LST) with Diffuse Large B-Cell Lymphoma Core Needle Biopsy Samples. Blood. 126(23). 1481–1481. 1 indexed citations

10.

Wallden, Brett, Sean Ferree, Harini Ravi, et al.. (2015). Development of the molecular diagnostic (MDx) DLBCL Lymphoma Subtyping Test (LST) on the nCounter Analysis System.. Journal of Clinical Oncology. 33(15_suppl). 8536–8536. 9 indexed citations

11.

Nielsen, Torsten O., Brett Wallden, Carl Schaper, et al.. (2014). Analytical validation of the PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay and nCounter Analysis System using formalin-fixed paraffin-embedded breast tumor specimens. BMC Cancer. 14(1). 177–177. 211 indexed citations

12.

Nielsen, Torsten O., Karsten Bjerre, Shuzhen Liu, et al.. (2013). PAM50 breast cancer intrinsic subtypes and effect of gemcitabine in advanced breast cancer patients. Acta Oncologica. 53(6). 776–787. 24 indexed citations

13.

Nielsen, TO, et al.. (2012). Abstract P3-06-03: Association between PAM50 breast cancer intrinsic subtypes and effect of gemcitabine in advanced breast cancer patients. Cancer Research. 72(24_Supplement). P3–6. 2 indexed citations

14.

Kamath‐Loeb, Ashwini S., Eitan Glick, Brett Wallden, et al.. (2009). Werner syndrome gene variants in human sarcomas. Molecular Carcinogenesis. 49(2). 166–174. 7 indexed citations

15.

Swift, Mari E., Brett Wallden, Elizabeth A. Wayner, & Karen Swisshelm. (2006). Truncated RAR beta isoform enhances proliferation and retinoid resistance. Journal of Cellular Physiology. 209(3). 718–725. 11 indexed citations

16.

Wallden, Brett, Mary J. Emond, Mari E. Swift, Mary L. Disis, & Karen Swisshelm. (2005). Antimetastatic gene expression profiles mediated by retinoic acid receptor beta 2 in MDA-MB-435 breast cancer cells. BMC Cancer. 5(1). 140–140. 11 indexed citations

17.

Wallden, Brett, et al.. (1970). A Comparative Study of Ibuprofen and Calcium-Acetylsalicylic Acid in Rheumatoid Arthritis. Lara D. Veeken. 10(suppl_1). 83–87. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact